KEGG: sce:YPL252C
STRING: 4932.YPL252C
YAH1 functions as a small iron-sulfur protein in the mitochondria of Saccharomyces cerevisiae. It serves as a critical component in the electron transfer chain, transferring electrons through ferredoxin reductase to terminal acceptors such as cytochrome P450 enzymes. YAH1 plays several essential roles:
Critical downstream regulatory target in the Hippo signaling pathway, crucial for organ size control and tumor suppression by restricting proliferation and promoting apoptosis
Essential for iron-sulfur (Fe-S) cluster biogenesis and assembly in mitochondria
Involved in mitochondrial integrity and function
Regulates the cortical actomyosin network, affecting tissue tension and 3D tissue shape
The yeast YAH1 is homologous to human FDX1 (Ferredoxin-1), which performs similar functions in human cells but specifically reduces mitochondrial CYP enzymes essential for adrenal steroidogenesis, bile acid formation, and vitamin D synthesis .
A methodological approach to validate YAH1 antibodies includes:
Western Blot Analysis: Confirm a single band at the expected molecular weight (approximately 19 kDa theoretical, but often observed at 14 kDa) . Compare wild-type cells with YAH1 knockout or knockdown cells.
Immunoprecipitation Controls: Perform IP with the antibody followed by mass spectrometry analysis to confirm pull-down of YAH1/FDX1 protein.
Immunofluorescence Cross-validation: Validate subcellular localization by co-staining with established mitochondrial markers.
Heterologous Expression Systems: Test against recombinant YAH1/FDX1 protein expressed in bacteria or mammalian cells.
Peptide Competition Assay: Pre-incubate the antibody with immunizing peptide before application to confirm specific binding.
| Validation Technique | Expected Result | Common Pitfalls |
|---|---|---|
| Western blot | Single band at ~14-19 kDa | Non-specific bands from cross-reactivity |
| Immunofluorescence | Mitochondrial localization | Background cytoplasmic staining |
| IP-Mass Spec | YAH1/FDX1 as dominant hit | Contamination with abundant proteins |
| Peptide competition | Signal abolishment | Incomplete blocking |
| Yeast knockout controls | Absence of signal | Leaky expression in KO systems |
For successful Western blotting with YAH1 antibodies, consider these methodological details:
Sample Preparation:
Isolate mitochondrial fractions for enrichment of target protein
Include protease inhibitors and reducing agents (DTT or β-mercaptoethanol) to protect iron-sulfur clusters
Avoid prolonged storage of samples before electrophoresis
Electrophoresis Conditions:
Use 12-15% polyacrylamide gels for optimal resolution of small proteins
Include positive controls such as recombinant YAH1/FDX1
Transfer and Blocking:
PVDF membranes typically work better than nitrocellulose for small proteins
Transfer at lower voltage (30V) overnight at 4°C for efficient transfer
Block with 5% non-fat milk in TBS-T (BSA may be necessary for phospho-specific antibodies)
Antibody Incubation:
Detection System:
Use high-sensitivity ECL substrates for enhanced detection
Consider fluorescent secondary antibodies for quantitative analysis
For effective immunoprecipitation of YAH1/FDX1:
Cell Lysis Optimization:
Use gentle lysis buffers containing 150-300mM NaCl, 1% NP-40 or Triton X-100, 50mM Tris pH 7.4
Include protease inhibitors, phosphatase inhibitors, and 1-2mM DTT
Perform lysis at 4°C with minimal mechanical disruption
Pre-clearing Step:
Pre-clear lysate with Protein A/G beads to reduce non-specific binding
Centrifuge at 14,000g for 10 minutes before antibody addition
Antibody Incubation:
Use 2-5μg antibody per 500μg-1mg protein lysate
Incubate with rotation overnight at 4°C
Add 30-50μl of pre-equilibrated Protein A/G beads and incubate for 2-4 hours
Washing Conditions:
Use at least 4 washes with decreasing salt concentration
Final wash should be with PBS to remove detergents
Elution and Analysis:
Elute by boiling in SDS sample buffer or use a peptide competition approach for native elution
Confirm IP efficiency by Western blot and consider mass spectrometry for interaction partners
Investigating iron-sulfur cluster biogenesis with YAH1 antibodies requires multifaceted approaches:
In vivo Fe-S Cluster Formation Assays:
Proximity-dependent Labeling:
Create YAH1-BioID or YAH1-APEX2 fusions to identify proximal proteins in the Fe-S biogenesis pathway
Validate interactions with co-immunoprecipitation using YAH1 antibodies
Structure-Function Studies:
Use YAH1 antibodies to pull down mutant variants with altered Fe-S binding domains
Combine with activity assays to correlate structural integrity with functional output
Stress Response Analysis:
Monitor YAH1 protein levels under oxidative stress, iron starvation, or copper excess
Correlate with enzymatic activities of Fe-S dependent enzymes
Research has shown that 55Fe turnover assays reveal that FeS integrity of Yah1 is particularly vulnerable to copper among tested proteins, and destabilization of the FeS domain of Yah1 produces copper hypersensitivity .
To investigate YAH1's involvement in copper response:
Copper Sensitivity Assays:
Molecular Interaction Studies:
Investigate interactions between YAH1 and copper homeostasis proteins
Use YAH1 antibodies for co-immunoprecipitation under normal and high copper conditions
Transcriptional Regulation Analysis:
Examine how copper influences YAH1 expression levels
Monitor downstream targets upon YAH1 perturbation during copper stress
Mitochondrial Function Assessment:
Measure electron transport chain activity in YAH1-depleted cells with/without copper
Analyze mitochondrial membrane potential and ROS production
Research has demonstrated that YAH1 overexpression rescues Rli1 dysfunction in copper toxicity conditions, and this copper-resistance function is conserved in the human ferredoxin, Fdx2 .
Different yeast genetic backgrounds present unique challenges when working with YAH1 antibodies:
Strain-Specific Expression Levels:
Epitope Accessibility Considerations:
Genetic background may influence post-translational modifications affecting antibody binding
Consider using multiple antibodies targeting different epitopes
Validate each new strain background with appropriate controls
Genetic Interaction Analysis:
When studying double mutants, consider synthetic interactions that might alter YAH1 detection
Use quantitative Western blotting to accurately compare expression levels
Cross-species Applications:
When transitioning between yeast species (S. cerevisiae vs. C. albicans), validate epitope conservation
Consider creating species-specific antibodies for divergent regions
For comprehensive mitochondrial function analysis:
Multimodal Imaging:
Combine immunofluorescence using YAH1 antibodies with live-cell imaging of mitochondrial potential
Correlate YAH1 localization with mitochondrial dynamics during stress responses
Implement super-resolution microscopy to visualize YAH1 distribution within mitochondrial subcompartments
Metabolic Profiling Integration:
Compare metabolomic profiles between wild-type and YAH1-depleted cells
Correlate YAH1 protein levels with changes in TCA cycle intermediates
Measure oxygen consumption rates in conjunction with YAH1 expression analysis
Proteomics Approaches:
Use quantitative proteomics to identify changes in the mitochondrial proteome upon YAH1 manipulation
Implement thermal proteome profiling to assess YAH1 stability under different conditions
Analyze post-translational modifications of YAH1 and interacting partners
Transcriptional Response Analysis:
Combine ChIP-seq using YAH1 antibodies with RNA-seq to correlate YAH1 binding with gene expression
Identify transcription factors that regulate YAH1 expression during mitochondrial stress
For investigating YAH1's involvement in the Hippo pathway:
Co-immunoprecipitation Studies:
Use YAH1 antibodies to pull down complexes and identify interactions with Hippo pathway components
Perform reciprocal IPs with Hippo pathway proteins to validate interactions
Map interaction domains through truncation mutants
Phosphorylation Dynamics:
Analyze YAH1 phosphorylation status in response to Hippo pathway activation/inhibition
Utilize phospho-specific antibodies to track activity-dependent modifications
Subcellular Localization Studies:
Track YAH1 trafficking between mitochondria and other cellular compartments during Hippo signaling
Implement proximity ligation assays to validate in situ interactions
Transcriptional Regulation Analysis:
Examine how YAH1 affects TEAD-dependent transcription through reporter assays
Analyze YAP1/TAZ nuclear translocation in cells with altered YAH1 levels
YAH1 has been identified as a critical downstream regulatory target in the Hippo signaling pathway, crucial for organ size control and tumor suppression by restricting proliferation and promoting apoptosis .
When encountering non-specific binding:
Antibody Validation Strategies:
Test multiple antibody clones targeting different epitopes
Validate with knockout/knockdown controls and overexpression systems
Consider using tagged versions of YAH1 with antibodies against the tag
Protocol Optimization:
Increase blocking stringency (5% BSA or commercial blocking agents)
Apply higher dilution of primary antibody (1:5000-1:6000)
Increase washing duration and number of wash steps
Add 0.1-0.5% SDS to wash buffer for high stringency
Sample Preparation Considerations:
Enrich for mitochondrial fractions to increase signal-to-noise ratio
Reduce sample loading to minimize background
Consider native vs. denaturing conditions based on epitope accessibility
Detection System Adjustment:
Use highly specific secondary antibodies with minimal cross-reactivity
Consider fluorescent secondaries for quantitative analysis and multiplex detection
For iron homeostasis studies:
Iron Supplementation/Chelation Experiments:
Design dose-response studies with iron chelators (e.g., BPS, DFO)
Test recovery with iron supplementation after depletion
Monitor YAH1 levels throughout iron perturbation
Fe-S Cluster Transfer Assays:
Measure transfer efficiency from YAH1 to recipient proteins in vitro
Compare wild-type YAH1 with mutant variants in transfer capability
Correlate with functional outputs of recipient proteins
Iron-specific Cellular Imaging:
Implement iron-specific probes alongside YAH1 immunostaining
Correlate iron distribution with YAH1 localization
Use electron microscopy with gold-labeled antibodies for ultrastructural analysis
Genetic Interaction Studies:
Create double mutants with iron regulatory genes
Assess synthetic phenotypes with iron transporters or regulators
Use quantitative growth assays under iron limitation/excess
YAH1 has been found to be particularly vulnerable to copper toxicity, which may have implications for iron-sulfur cluster integrity and subsequent iron homeostasis mechanisms .